Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals by Marita Nittner-Marszalska, Marta Rosiek-Biegus, Agnieszka Kopeć, Robert Pawłowicz, Magdalena Kosińska, Aleksandra Łata, Leszek Szenborn

“…We sought to assess the tolerance towards the Pfizer-BioNTech vaccine in allergic patients. To address this issue, we used a questionnaire conducted on-line in a group of medical professionals who were vaccinated with the Pfizer-BioNTech vaccine. …”
Get full text

Prolonged Anaphylaxis to Pfizer Coronavirus Disease 2019 Vaccine: A Case Report and Mechanism of Action by Ashleigh Frank, DO, Sara Radparvar, PharmD, BCPS, BCCCP, Anthony Manasia, MD, FCCP, Adel Bassily-Marcus, MD, Roopa Kohli-Seth, MD

“…In response to the devastating effects of the coronavirus disease 2019 pandemic, several vaccine prototypes have been developed, with the Pfizer/BioNTech (BNT162b2) platform being the first to receive emergency use authorization. …”
Get full text

Portal vein thrombosis after second Pfizer/BioNTech coronavirus disease 2019 vaccine by Jameson M. Petrochko, MD, Shaun M. Pateman Aciu, MD, Sharvil U. Sheth, MD

“…We have reviewed a case of portomesenteric venous thrombosis that occurred shortly after the administration of the second Pfizer/BioNTech coronavirus disease 2019 (COVID-19) vaccine and discussed the literature surrounding the subject. …”
Get full text

Analysis of intracranial haemorrhage following tozinameran (BNT162b2, Pfizer-BioNTech) by Yohhei Hamada

Get full text

Cross-Reactivity between Half Doses of Pfizer and AstraZeneca Vaccines—A Preliminary Study by Krzysztof Lukaszuk, Amira Podolak, Paulina Malinowska, Jakub Lukaszuk, Grzegorz Jakiel

Subjects: Get full text

A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine by José Carlos de la Flor Merino, Tania Linares Gravalos, Marina Alonso-Riaño, Pilar Segura Cebollada, Cristina Albarracin Serra, Elisa Ruiz Cicero, Gioconda Gallegos Bayas, Miguel Rodeles del Pozoa

Get full text

Efficacy of Pfizer vaccine on IL-12/IFN-γ pathway with related to COVID-19 infection by Surhan Ruaa Kareem, Darweesh Mayyada F.

“…However, this study design to evaluate effectiveness of Pfizer vaccine on serum level for IL-12/IFN-γ pathway with susceptibility to COVID-19. …”
Get full text

Multilayered Politicized Constructions of Covid-19 Vaccines: A Global South View of Pfizer and Sinovac by Ed Joseph B. Bulilan, Joshua Uyheng, Cristina J. Montiel

“…Harnessing a mixed methods research design, we apply this framework to analyze a large corpus of Filipino tweets (N = 229,236) about the Pfizer and Sinovac vaccines. Micro-level discourses feature competing individual emotions which construct Pfizer as an object of desire and Sinovac as an object of fear. …”
Get full text

Potential Triggers for Thrombocytopenia and/or Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech by Yusuke Okada, Ryota Sakai, Marie Sato-Fitoussi, Marika Nodera, Shoichi Yoshinaga, Akiko Shibata, Takahiko Kurasawa, Tsuneo Kondo, Koichi Amano

“…Although available published data do not associate the BNT162b2 vaccine (Pfizer-BioNTech) with the risk of developing thrombocytopenia, the ChAdOx1 nCov-19 vaccine has raised concerns about its potential link with thrombosis and thrombocytopenia. …”
Get full text

Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine by Carol Tay, Damien Lai

Get full text

A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson by Rikin Patel, Mohamad Kaki, Venkat S. Potluri, Payal Kahar, Deepesh Khanna

Subjects: Get full text

Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine by Giovanni Paolino, MD, PhD, Franco Rongioletti, MD

Get full text

Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia by Farhat M, Al-Ibrahim R, Almohammedali A, Aljishi R, Alalwan B

Subjects: Get full text

Public-private partnerships to build human capacity in low income countries: findings from the Pfizer program by Connelly Patrick, McCoy Kelly, Richards Sarah C, Vian Taryn, Feeley Frank

“…From 2003 to 2005, the Pfizer Global Health Fellows program sent 72 employees to work with organizations in 19 countries. …”
Get full text

6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers by Jason Cham, Amitabh C. Pandey, Jacob New, Tridu Huynh, Lee Hong, Natalia Orendain, Eric J. Topol, Laura J. Nicholson

“…<h4>Aim</h4> Healthcare workers (HCWs) were among the first group of people vaccinated with the Pfizer-BioNTech Covid-19 vaccine (BNT162b2). Characterization of the kinetics of antibody response to vaccination is important to devise future vaccination strategies. …”
Get full text

Management of cardiovascular symptoms after Pfizer-BioNTech COVID-19 vaccine in teenagers in the emergency department by Ying-Feng Liao, Wei-Chieh Tseng, Jou-Kou Wang, Yih-Sharng Chen, Chun-An Chen, Ming-Tai Lin, Chun-Wei Lu, Mei-Hwan Wu, Shuenn-Nan Chiu

“…Background: Cardiovascular complications after Pfizer–BioNTech COVID-19 (BNT) vaccination are a concern, especially in adolescents. …”
Get full text

Good news reduces trust in government and its efficacy: The case of the Pfizer/BioNTech vaccine announcement. by Shaun P Hargreaves Heap, Christel Koop, Konstantinos Matakos, Aslı Unan, Nina Weber

“…The announcement of Pfizer/BioNTech's COVID-19 vaccine success on November 9, 2020 led to a global stock market surge. …”
Get full text

Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine by Maayan Aharoni, Avi Leader, Tzippy Shochat, Pia Raanani, Galia Spectre

Subjects: Get full text

Mason-Pfizer Monkey Virus Envelope Glycoprotein Cycling and Its Vesicular Co-Transport with Immature Particles by Petra Grznárová Prokšová, Jan Lipov, Jaroslav Zelenka, Eric Hunter, Hana Langerová, Michaela Rumlová, Tomáš Ruml

Subjects: “…Mason-Pfizer monkey virus…”
Get full text

6 month serologic response to the Pfizer-BioNTech COVID-19 vaccine among healthcare workers. by Jason Cham, Amitabh C Pandey, Jacob New, Tridu Huynh, Lee Hong, Natalia Orendain, Eric J Topol, Laura J Nicholson

“…<h4>Aim</h4>Healthcare workers (HCWs) were among the first group of people vaccinated with the Pfizer-BioNTech Covid-19 vaccine (BNT162b2). Characterization of the kinetics of antibody response to vaccination is important to devise future vaccination strategies. …”
Get full text